DK163210C - Fremgangsmaade til inaktivering af et lipidvirus i form af hepatitis b virus og/eller non-a, non-b hepatitis virus - Google Patents

Fremgangsmaade til inaktivering af et lipidvirus i form af hepatitis b virus og/eller non-a, non-b hepatitis virus

Info

Publication number
DK163210C
DK163210C DK057284A DK57284A DK163210C DK 163210 C DK163210 C DK 163210C DK 057284 A DK057284 A DK 057284A DK 57284 A DK57284 A DK 57284A DK 163210 C DK163210 C DK 163210C
Authority
DK
Denmark
Prior art keywords
virus
hepatitis
inactivating
lipid
hepatitis virus
Prior art date
Application number
DK057284A
Other languages
English (en)
Other versions
DK57284A (da
DK57284D0 (da
DK163210B (da
Inventor
Robert H Purcell
Stephen M Feinstone
Original Assignee
Robert H Purcell
Stephen M Feinstone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert H Purcell, Stephen M Feinstone filed Critical Robert H Purcell
Publication of DK57284A publication Critical patent/DK57284A/da
Publication of DK57284D0 publication Critical patent/DK57284D0/da
Publication of DK163210B publication Critical patent/DK163210B/da
Application granted granted Critical
Publication of DK163210C publication Critical patent/DK163210C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation
    • C12N2730/10163—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24261—Methods of inactivation or attenuation
    • C12N2770/24263—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK057284A 1982-06-10 1984-02-09 Fremgangsmaade til inaktivering af et lipidvirus i form af hepatitis b virus og/eller non-a, non-b hepatitis virus DK163210C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/386,991 US4511556A (en) 1982-06-10 1982-06-10 Inactivation of a lipid virus
US38699182 1982-06-10
US8300884 1983-06-07
PCT/US1983/000884 WO1983004371A1 (en) 1982-06-10 1983-06-07 Inactivation of a lipid virus

Publications (4)

Publication Number Publication Date
DK57284A DK57284A (da) 1984-02-09
DK57284D0 DK57284D0 (da) 1984-02-09
DK163210B DK163210B (da) 1992-02-10
DK163210C true DK163210C (da) 1992-06-29

Family

ID=23527965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK057284A DK163210C (da) 1982-06-10 1984-02-09 Fremgangsmaade til inaktivering af et lipidvirus i form af hepatitis b virus og/eller non-a, non-b hepatitis virus

Country Status (11)

Country Link
US (1) US4511556A (da)
EP (1) EP0111549B1 (da)
AU (1) AU560366B2 (da)
CA (1) CA1198056A (da)
DE (1) DE3377971D1 (da)
DK (1) DK163210C (da)
ES (1) ES8503721A1 (da)
FI (1) FI79025C (da)
IT (1) IT1170391B (da)
PT (1) PT76845B (da)
WO (1) WO1983004371A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3434472A1 (de) * 1984-09-20 1986-03-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur pasteurisation von plasmaproteinen bzw. von plasmaproteinfraktionen
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
AT390374B (de) * 1986-03-18 1990-04-25 Schwab & Co Gmbh Verfahren zum pasteurisieren von plasmaprotein und plasmaproteinfraktionen
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
US8956566B2 (en) 2012-03-12 2015-02-17 Pure Biosolutions, Llc System and method for virus inactivation
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations
US4230697A (en) * 1978-07-03 1980-10-28 Morinaga Milk Industry Co. Ltd. Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same

Also Published As

Publication number Publication date
DE3377971D1 (en) 1988-10-20
PT76845B (en) 1986-01-10
DK57284A (da) 1984-02-09
AU1772083A (en) 1983-12-30
WO1983004371A1 (en) 1983-12-22
DK57284D0 (da) 1984-02-09
EP0111549A1 (en) 1984-06-27
AU560366B2 (en) 1987-04-02
FI79025C (fi) 1989-11-10
DK163210B (da) 1992-02-10
US4511556A (en) 1985-04-16
FI840512A0 (fi) 1984-02-08
EP0111549B1 (en) 1988-09-14
CA1198056A (en) 1985-12-17
IT8348461A0 (it) 1983-06-09
FI79025B (fi) 1989-07-31
ES523117A0 (es) 1985-03-01
ES8503721A1 (es) 1985-03-01
FI840512L (fi) 1984-02-08
EP0111549A4 (en) 1985-02-28
IT1170391B (it) 1987-06-03
PT76845A (en) 1983-07-01

Similar Documents

Publication Publication Date Title
DK163210C (da) Fremgangsmaade til inaktivering af et lipidvirus i form af hepatitis b virus og/eller non-a, non-b hepatitis virus
IT1138449B (it) Saggio e vaccino per epatite non-a,non-b
DK210283D0 (da) Fremgangsmade til fremstilling af plasma, plasmapraeparat og vaccine mod hepatitis
FI894580A7 (fi) Non-A, non-B-hepatitisvirusantigeenipeptidi
NZ236491A (en) Post-transfusional non-a non-b hepatitis viral polypeptides, dna, antigenic polypeptides and antibodies to the polypeptides
DK643387D0 (da) T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein
ES2018648B3 (es) Metodo para la deteccion de proteinas y virus.
GB2108527B (en) Non-a non-b hepatitis virus
DK214889D0 (da) Ikke-vandigt, ikke-ionisk, kraftigt virkende vaskemiddel med forbedret stabilitet under anvendelse af mikrokugler og/eller vicinal-hydroxyforbindelser
FI942369L (fi) Hepatitis-C-virustesti
FR2344629A1 (fr) Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
FI910127A7 (fi) Ei-A-, ei-B-hepatiittiviruksen perimän cDNA ja antigeenipolypeptidi
DK323086A (da) Vacciner og diagnostica afledt af kvaegdiarre-virus
DK21789A (da) Koncentrater af koagulationsfaktorer ii, vii, ix og x, fremgangsmaade til deres fremstilling og anvendelse deraf
FI833205L (fi) Foerfarande foer framstaellning av ett hepatitis b-virusvaccin
DK88988D0 (da) T- og b-celleepitoper af pre-s-regionen af hepatitis-b-virus-overfladeantigen
FI892683A7 (fi) Menetelmä ei-hyperglykosyloitujen hepatiitti-B-virusproteiinien tuottamiseksi
FI934777A0 (fi) Multipel hepatitis b virus ytproteiner som bildar partiklar
DK16491D0 (da) Fremgangsmaade til behandling af form- og/eller kernesand
MX9100257A (es) Peptidos y analogos y mezclas de los mismos para la deteccion de anticuerpos en virus htlv-1 htlv-ii
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
DE3377401D1 (de) Non-a, non-b hepatitis antigen
DK196689A (da) Ekspression af praes2-proteinet for hepatitis b i methylotrophe gaerarter
EP0082789A3 (en) Immunological composition and method for hepatitis b virus
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.

Legal Events

Date Code Title Description
PBP Patent lapsed